Dr. Emma Devenney is a cognitive neurologist and neuroscientist whose research focuses on the early diagnosis and biomarker development for neurodegenerative diseases, including frontotemporal dementia, Alzheimer’s disease, and motor neurone disease. She has a particular interest in how genetic risk influences cognition and behaviour across the disease course. Additionally, advancing equity in global dementia care and research by addressing disparities in diagnosis, access to interventions, and representation in biomarker and clinical studies across diverse populations. Dr. Devenney is actively involved in international research collaborations, including with the University of San Francisco, University of London, and University of Amsterdam, and is a Principal Investigator for the NIH-funded Dominantly Inherited Alzheimer’s Disease Network in Sydney. Dr. Devenney received her PhD in neuroscience from UNSW, supported by an international scholarship, and completed advanced clinical and research training in the UK and Australia. Currently a Senior Research Fellow at Neuroscience Research Australia, she holds an NHMRC Emerging Leadership Fellowship and collaborates internationally to improve diagnostic tools and treatment pathways for people at risk of or living with dementia.